OncoHelix will now offer the validated ClarityDX Prostate Risk Score to healthcare providers and their patients suspected of having aggressive prostate cancer. ClarityDX Prostate is a blood-based ...

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

A new study is set to investigate how AI could significantly improve doctors’ decisions regarding prostate cancer treatment. While diagnostic methods for the disease have become safer and more precise ...

Scientists at the University of Cambridge, in collaboration with researchers at the Institute of Cancer Research, London, have developed a new computational algorithm to help predict a man's ...

CLEVELAND, Ohio — When it comes to cancer, deciding on the best course of treatment can sometimes feel like a coin toss. However, doctors at University Hospitals have a new tool that helps them weigh ...

News that former President Joseph Biden has advanced prostate cancer has revived long-standing questions about the benefits versus the harms of a blood test that screens for the most commonly ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with ...

The UCLA trial is currently enrolling patients.

Sept. 18, 2025 -- About 1 in 8 men will face a prostate cancer diagnosis. Early-stage prostate cancer often has no symptoms—so how should men approach screening and advocacy? What disparities do Black ...

The prostate gland, nestled beneath the bladder and in front of the rectum, plays a vital role in male reproductive health by producing fluid for semen. While prostate cancer often develops slowly, ...